Natural killer cell activity in monoclonal gammopathies: Relation to disease activity
- 1 September 1990
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 45 (3) , 153-157
- https://doi.org/10.1111/j.1600-0609.1990.tb00443.x
Abstract
Natural killer (NK) activity and NK‐related cell surface markers (CD16, CD56, CD57) of peripheral blood lymphocytes were studied in patients with multiple myeloma and MGUS (monoclonal gammopathy of undetermined significance). A strong correlation (p < 0.0001) was found between the numbers of cells positive for the different NK cell surface markers. The proportion of CD16+cells correlated highly to the lytic capability (lytic units/106cells) of K562 cells (p < 0.0001). High NK activity and high numbers of cells with NK‐related cell surface markers were found in patients with a low tumor burden compared to controls, whereas low values were seen in patients with an advanced disease. The results indicate that NK cells might be involved in the disease process in monoclonal gammopathies, perhaps by exerting a regulatory function on the proliferating B‐cell clone.Keywords
This publication has 26 references indexed in Scilit:
- Decreased natural killer cell activity versus normal natural killer cell markers in mononuclear cells from patients with smouldering leukemiaScandinavian Journal of Haematology, 2009
- Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCSEuropean Journal of Haematology, 1989
- Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myelomaEuropean Journal of Cancer and Clinical Oncology, 1983
- Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-αInternational Journal of Cancer, 1982
- T Cells in Monoclonal GammopathiesScandinavian Journal of Haematology, 1982
- Monoclonal Blood Lymphocytes in Benign Monoclonal Gammopathy and Multiple Myeloma in Relation to Clinical StageScandinavian Journal of Haematology, 1981
- Distribution of Natural Killer Cell Activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro treatment with interferon preparationClinical Immunology and Immunopathology, 1981
- Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targetsCellular Immunology, 1979
- Intermittent Melphalan and Prednisolone Therapy in Plasma Cell MyelomaActa Medica Scandinavica, 1977
- Spontaneous human lymphocyte‐mediated cytotoxicity againts tumour target cells. I. The effect of malignant diseaseInternational Journal of Cancer, 1976